Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Short-term NSAID Use in Postoperative Pediatric CKD Patients
NCT06860711Phase 4Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Jul 2025
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketorolac and ibuprofen in postoperative pain (2 arms), sponsored by University of Colorado Denver. Primary endpoint: Frequency of Acute Kidney Injury at 14 days. Started Jul 2025; status: recruiting.
02
Drugs
ketorolacibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06860711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06860711.